CCND1 and breast cancer: Interestingly enough, Li et al [32], have reported an optimal cut-off point of immunostaining scores of cyclin D1 protein, which could be used to predict the status of CCND1 gene and identify a subgroup of ER positive breast cancers with poor response to endocrine agents.